Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Voyager Therapeutics Stock (NASDAQ:VYGR), Quotes and News Summary

Q: What sector and industry does Voyager Therapeutics (VYGR) operate in?

Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Voyager Therapeutics Stock (NASDAQ: VYGR) stock price, news, charts, stock research, profile.

Open	$7.500
Close	-
Volume / Avg.	102.700K / 634.442K
Day Range	7.400 - 7.660
52 Wk Range	6.060 - 14.340
Market Cap	$418.658M
P/E Ratio	2.542
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	7.33%
Days to Cover	4.19

Recent News

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term value.

Vandana Singh

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.

Piero Cingari

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Voyager Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments fo...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Voyager Therapeutics (VYGR) stock?

You can purchase shares of Voyager Therapeutics (NASDAQ: VYGR) through any online brokerage.

View our list of the best stock brokerages.

Who are Voyager Therapeutics's (VYGR) competitors?

Other companies in Voyager Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Humacyte (NASDAQ:HUMA), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and PepGen (NASDAQ:PEPG).

What is the target price for Voyager Therapeutics (VYGR) stock?

The latest price target for Voyager Therapeutics (NASDAQ: VYGR) was reported by Guggenheim on Tuesday, March 26, 2024. The analyst firm set a price target for 22.00 expecting VYGR to rise to within 12 months (a possible 185.34% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Voyager Therapeutics (VYGR)?

The stock price for Voyager Therapeutics (NASDAQ: VYGR) is $7.71 last updated Today at April 19, 2024 at 7:44 AM EDT.

Does Voyager Therapeutics (VYGR) pay a dividend?

There are no upcoming dividends for Voyager Therapeutics.

When is Voyager Therapeutics (NASDAQ:VYGR) reporting earnings?

Voyager Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Voyager Therapeutics (VYGR) going to split?

There is no upcoming split for Voyager Therapeutics.

What sector and industry does Voyager Therapeutics (VYGR) operate in?

Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-